A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with 223Radium-dichloride.
Viviana FrantellizziAlessio FarcomeniGiulia Anna FollacchioMassimiliano PacilioRosanna PellegriniRoberto PaniGiuseppe De VincentisPublished in: Annals of nuclear medicine (2017)
We propose a multidimensional clinical evaluation to select those mCRPC subjects suitable to receive the maximum benefit from 223Ra treatment.